Denali CEO’s Jan 6 Share Sale: A Routine Tax Move, Not a Bear Signal
Denali CEO’s January sale is a tax‑plan move, not a warning. Focus on the company’s neuro‑degeneration pipeline and upcoming FDA milestones for real value.
3 minutes to read
Denali Therapeutics Inc